News Sigrid Therapeutics launches Glucose Stabiliser in the US, an over-the-counter dietary supplement designed to control blood sugar and body weight Stockholm, November 14, 2023. Sigrid Therapeutics today announced that the company has launched Glucose Stabiliser…SanaNovember 14, 2023
News Sigrid Therapeutics Secures $4 Million in Oversubscribed Funding Round to Tap Into Booming Obesity and Diabetes Market Both Nordic and international investors were attracted by Sigrid’s natural, non-drug alternative SiPore® Stockholm, Sweden,…SanaOctober 31, 2023
News Sigrid Therapeutics announces appointment of distinguished Professor Iain Chapple to Scientific Advisory Board World-renowned oral healthcare expert joins Sigrid’s SAB to investigate impact of the SiPore® technology on…SanaMay 10, 2023
News Sigrid Therapeutics unveils SiPore® plaque blocker at IDS 2023 Sigrid Therapeutics unveils SiPore® to prevent oral pathogenic bacterial growth and plaque formation at International…SanaMarch 14, 2023
News Sigrid Therapeutics rapporterar positiva resultat från konsumenttest av SiPore®, en produkt avsedd för prediabetiker, typ 2-diabetiker och överviktiga för kontroll av blodsockernivån Produkten, som tas i form av kapsel eller gel förhindrar att en del av matsmältningsenzymerna…SanaMarch 8, 2023
News Sigrid Therapeutics reports positive results from consumer blood sugar management trial using SiPore® formulated dietary supplements in pre-diabetics, type 2 diabetics, and obese individuals “Molecular sieves” swallowed in capsules and gels reported safe, easy to digest and effective Stockholm,…SanaMarch 8, 2023
News Sigrid Therapeutics tar in ytterligare 10,6 miljoner kronor i övertecknad företrädesemission för att påskynda kommersialiseringen av SiPore® Sigrid Therapeutics tar in ytterligare 10,6 miljoner kronor i övertecknad företrädesemission för att påskynda kommersialiseringen…SanaJanuary 17, 2023
News Sigrid Therapeutics raises further SEK10.6 million in oversubscribed rights issue for accelerated SiPore® commercialization Sigrid Therapeutics raises further SEK10.6 million in oversubscribed rights issue for accelerated SiPore® commercialization Swedish…SanaJanuary 17, 2023
News Sigrid Therapeutics utser Mattias Ankerberg, en internationell ledarprofil från konsumentvarubranschen till ordförande Sigrid Therapeutics utser Mattias Ankerberg, en internationell ledarprofil från konsumentvarubranschen till ordförande Företaget siktar mot…SanaOctober 24, 2022
News Sigrid Therapeutics appoints internationally established consumer industry executive Mattias Ankarberg as Chairman Sigrid Therapeutics appoints internationally established consumer industry executive Mattias Ankarberg as Chairman Company aims to…SanaOctober 24, 2022